Literature DB >> 35671760

Lung Cancer: Epidemiology and Screening.

Aundrea L Oliver1.   

Abstract

Lung Cancer remains the leading cause of cancer mortality in the United States and Worldwide. Incidence and mortality have been on the decline in the United States, while worldwide cases continue to increase. Risk factor modification and screening are critical to improving survival in patients with lung cancer. Identifying at-risk populations for access to care and screening programs will improve overall outcomes. Understanding environmental and carcinogenic sources are integral to public health policy and education. Innovations in population health and translational research will be essential in the future to improve lung cancer survival.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Disparities; Epidemiology; Lung cancer; Screening

Year:  2022        PMID: 35671760     DOI: 10.1016/j.suc.2021.12.001

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  4 in total

1.  Study on Effects of Cyclophosphamide Combined with Vinorelbine in Advanced Small Cell Lung Cancer and Anteroposterior Changes in MRI.

Authors:  Zhichun Li; Liliang Ren
Journal:  Contrast Media Mol Imaging       Date:  2022-08-08       Impact factor: 3.009

2.  A predictive model based on ground glass nodule features via high-resolution CT for identifying invasiveness of lung adenocarcinoma.

Authors:  Bo Yan; Yuanyuan Chang; Yifeng Jiang; Yuan Liu; Junyi Yuan; Rong Li
Journal:  Front Surg       Date:  2022-08-26

3.  Prognostic nomograms for lung neuroendocrine carcinomas based on lymph node ratio: a SEER database analysis.

Authors:  Lan Xiong; Youfan Jiang; Tianyang Hu
Journal:  J Int Med Res       Date:  2022-09       Impact factor: 1.573

Review 4.  Advances in the application of proteomics in lung cancer.

Authors:  Bai Ling; Zhengyu Zhang; Ze Xiang; Yiqi Cai; Xinyue Zhang; Jian Wu
Journal:  Front Oncol       Date:  2022-09-27       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.